Who invested in Asklepios BioPharmaceuticals?
Asklepios BioPharmaceuticals's investors include TPG and Vida Ventures.
United States · Funded startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$235Mraised across 1 round since 2019, from 1 source
Asklepios BioPharmaceuticals's investors include TPG and Vida Ventures.
Asklepios BioPharmaceuticals has raised $235M across 1 round since 2019.
Asklepios BioPharmaceuticals's most recent round was an Undisclosed round of $235M in Apr 2019.
Its most recent round, $235M in Apr 2019, is also its largest on record.
Asklepios BioPharmaceuticals's first round on record, in Apr 2019, was backed by TPG and Vida Ventures.
Asklepios BioPharmaceuticals's latest named round is an Undisclosed round, in Apr 2019.
Asklepios BioPharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.